cute
coliti
common
caus
rapid
debilit
death
hors
untreat
hors
condit
die
euthan
hors
treat
appropri
usual
respond
gradual
recov
period
colitisassoci
diarrhea
sporad
occurr
character
intralumin
sequestr
fluid
moder
sever
colic
profus
wateri
diarrhea
result
endotoxemia
leukopenia
hypovolemia
condit
affect
adult
hors
age
usual
affect
hors
year
age
diseas
onset
sudden
progress
rapid
condit
often
preced
stress
event
definit
diagnosi
made
case
antemortem
postmortem
test
determin
etiolog
yield
definit
diagnosi
treatment
coliti
extrem
costli
substanti
volum
intraven
replac
fluid
requir
present
cur
treatment
treatment
strategi
direct
rehydr
electrolyt
plasma
protein
replac
prevent
amelior
effect
endotoxemia
provis
nutrit
support
administr
antimicrobi
indic
diarrhea
associ
acut
coliti
result
abnorm
fluid
ion
transport
cecal
colon
mucosa
fluid
loss
result
combin
malabsorpt
hypersecretori
process
normal
condit
water
electrolyt
secret
epitheli
cell
intestin
crypt
fluid
reabsorb
surfac
epitheli
cell
abnorm
rate
secret
absorpt
result
massiv
secret
malabsorpt
larg
intestin
mucos
epitheli
cell
lead
sever
dehydr
death
acut
coliti
gener
term
refer
inflamm
cecum
typhliti
colon
coliti
typhlocol
subsequ
rapid
onset
diarrhea
adult
hors
contrast
domest
anim
human
hors
sudden
massiv
fluid
loss
sever
electrolyt
imbal
result
death
hour
distinct
clinic
present
hors
may
result
sever
uniqu
featur
larg
bowel
equida
includ
larg
popul
gramneg
endotoxinbear
bacteria
resid
larg
intestin
markedli
high
mucos
prostaglandin
concentr
manifest
mark
chlorid
secretori
respons
compar
speci
anoth
possibl
reason
distinct
clinic
sign
intens
inflamm
result
activ
resid
intestin
mucos
submucos
phagocyt
granulocyt
intestin
bacteri
product
mucos
barrier
disrupt
caus
acut
coliti
review
fourth
edit
current
therapi
equin
medicin
pp
agreement
certain
distinct
clinic
patholog
diagnost
characterist
may
help
differenti
specif
acut
colitisassoci
condit
tabl
regardless
initi
caus
common
clinic
patholog
featur
suggest
common
pathophysiolog
pathway
typic
hematolog
find
includ
hypovolemia
dehydr
metabol
acidemia
electrolyt
derang
leukopenia
left
shift
toxic
neutrophil
lymphopenia
azotemia
clinic
featur
includ
depress
inappet
fever
tachycardia
dri
mucou
membran
skin
tent
prolong
capillari
refil
time
colic
wateri
often
fetid
diarrhea
gross
necropsi
find
usual
reveal
edemat
sometim
hemorrhag
typhlitiscol
intralumin
sequestr
fluid
ingesta
figur
common
microscop
abnorm
includ
superfici
mucos
injuri
affect
distal
portion
ileum
cecum
larg
colon
injuri
character
mucos
epitheli
ulcer
eros
mucos
submucos
edema
variou
degre
mucos
inflamm
lesion
may
enhanc
net
fluid
movement
intestin
lumen
decreas
net
solut
absorpt
increas
mucos
permeabl
stimul
prostaglandinmedi
ion
secret
disrupt
epithelium
allow
transmur
migrat
endotoxin
hors
impend
coliti
lethargi
inappet
colic
frequent
notic
sever
hour
appear
liquid
fece
physic
examin
earli
period
may
reveal
high
respiratori
heart
rate
secondari
abdomin
discomfort
intralumin
sequestr
fluid
ga
secondari
inflammatori
mediat
activ
rectal
temperatur
may
also
high
result
inflammatori
respons
toxin
absorpt
disrupt
intestin
mucos
barrier
sign
abdomin
discomfort
rang
mild
recumb
inappet
sever
hors
roll
thrash
abdomin
distens
often
evid
case
may
confus
larg
bowel
disord
larg
colon
torsion
acut
equin
coliti
consid
potenti
lifethreaten
emerg
earli
evalu
treatment
veterinarian
critic
hors
sudden
onset
coliti
sequest
larg
volum
fluid
intralumin
begin
pass
liquid
materi
within
sever
hour
volum
fluid
lost
intestin
tract
equal
hors
entir
extracellular
fluid
volum
henc
sign
dehydr
hypovolemia
may
sever
mucou
membran
may
brick
color
sticki
capillari
refil
time
prolong
skin
turgor
reduc
progress
sever
hypovolemia
subsequ
circulatori
shock
lead
purpl
mucou
membran
weak
peripher
puls
hors
acut
coliti
prone
lamin
may
develop
acut
coliti
hors
sign
addit
lifethreaten
complic
eg
lame
bound
digit
puls
high
hoof
temperatur
time
cours
diseas
assess
data
hors
blood
test
import
determin
degre
system
ill
plasma
volum
replac
need
pack
cell
volum
pcv
total
plasma
protein
tpp
valu
often
high
initi
indic
sever
dehydr
total
protein
valu
refer
rang
clinic
dehydr
hors
high
pcv
indic
overal
protein
loss
daili
pcv
tpp
assess
use
monitor
daili
fluid
protein
need
total
differenti
white
blood
cell
wbc
count
usual
reveal
neutropenia
left
shift
granulocyt
often
toxic
morpholog
chang
includ
cytoplasm
vacuol
basophilia
toxic
granul
format
bodi
sign
overal
improv
usual
correl
decreas
abnorm
wbc
featur
includ
morpholog
chang
hors
later
stage
acut
coliti
may
high
fibrinogen
concentr
neutrophil
leukocytosi
indic
gener
inflammatori
respons
hors
coliti
usual
metabol
acidemia
electrolyt
derang
includ
hyponatremia
hypochloremia
hypocapnia
hypokalemia
hypocalcemia
azotemia
patient
histori
extrem
use
determin
possibl
caus
acut
coliti
especi
includ
treatment
drug
nonsteroid
antiinflammatori
drug
nsaid
antimicrobi
anthelmint
chang
diet
inadequ
deworm
histori
stress
event
import
rule
salmonella
sppassoci
coliti
organ
pose
risk
infect
anim
constitut
potenti
zoonot
hazard
salmonella
organ
often
shed
intermitt
five
consecut
fecal
sampl
weigh
g
cultur
sensit
three
consecut
fecal
sampl
polymeras
chain
reaction
pcr
collect
interv
submit
neorickettsia
risticii
caus
agent
potomac
hors
fever
caus
biphas
fever
lamin
coliti
variabl
sever
diseas
widespread
mani
part
unit
state
especi
california
midatlant
state
canada
europ
highest
preval
diseas
observ
hors
resid
proxim
freshwat
pond
stream
temper
climat
diseas
common
late
spring
earli
fall
diagnosi
n
risticiiassoci
coliti
may
support
compar
pair
serum
titer
use
immunofluoresc
assay
test
techniqu
diagnosi
confirm
use
antigen
detect
identif
n
risticii
morula
wbc
acut
phase
diseas
isol
organ
wbc
pcr
test
wbc
fece
clostridium
difficil
implic
caus
acut
coliti
hors
treat
antimicrobi
mare
foal
undergo
treatment
rhodococcu
equi
pneumonia
untreat
hors
diarrhea
commerci
avail
cytotoxin
assay
c
difficil
toxin
b
cytotoxin
gene
use
diagnos
c
difficileassoci
diarrhea
test
base
enzymelink
immunosorb
assay
pcr
technolog
least
g
fece
submit
immedi
collect
transport
frozen
ice
airtight
contain
mount
evid
indic
equin
coronaviru
caus
acut
equin
coliti
fecal
pcr
equin
coronaviru
includ
screen
process
intestin
parasit
especi
encyst
cyathostom
may
play
role
caus
acut
coliti
although
effect
deworm
product
practic
made
less
concern
develop
resist
avail
anthelmint
product
intestin
parasit
prohibit
clinician
entir
rule
caus
although
fecal
egg
count
use
determin
role
parasit
immatur
encyst
larva
still
caus
intestin
inflamm
even
fecal
egg
count
low
investig
recent
begun
studi
microbiom
hors
without
coliti
investig
suggest
coliti
may
diseas
dysbiosi
rather
one
occur
simpli
overgrowth
individu
pathogen
care
hors
acut
coliti
aim
restor
plasma
volum
provid
analgesia
reduc
inflamm
block
effect
endotoxin
microb
support
patient
nutrit
intraven
polyion
fluid
administ
volum
base
total
fluid
deficit
calcul
clinic
assess
dehydr
eg
moder
dehydr
calcul
volum
deficit
would
kg
bodi
weight
l
fluid
deficit
replac
rapidli
l
per
hour
adult
hors
plasma
volum
restor
hors
well
hydrat
volum
fluid
administ
adjust
may
still
high
mlkg
daili
depend
ongo
loss
emerg
situat
blood
volum
rapidli
expand
cardiac
output
increas
intraven
administr
small
volum
hyperton
salin
l
salin
result
increas
blood
tonic
caus
fluid
move
rapidli
extracellular
fluid
space
vascular
compart
improv
microcirculatori
perfus
help
prevent
complic
sepsi
multiplesystem
organ
failur
hyperton
salin
administr
also
immunomodulatori
effect
antiinflammatori
effect
cardiac
inotrop
effect
wherea
polyion
crystalloid
induc
modest
increas
intravascular
volum
quickli
leav
intravascular
space
interstitium
hyperton
salin
increas
plasma
volum
three
four
time
volum
administ
volum
expans
may
last
minut
howev
import
rememb
hyperton
salin
replac
fluid
lost
diarrhea
reason
larg
volum
balanc
polyion
fluid
solut
administ
intraven
least
l
per
hour
hyperton
salin
administ
hydrat
deficit
correct
mani
hors
colitisassoci
dehydr
electrolyt
imbal
voluntarili
consum
variou
type
electrolyt
supplement
addit
offer
fresh
cleanwat
sourc
offer
mixtur
electrolyt
water
separ
pail
may
benefici
mixtur
consid
includ
water
bake
soda
gl
water
naclkcl
ie
lite
salt
gl
water
mix
commerci
electrolyt
solut
decreas
colloid
oncot
pressur
lead
decreas
effect
circul
fluid
volum
tissu
edema
hors
acut
coliti
total
plasma
protein
may
declin
g
dl
albumin
concentr
may
decreas
less
gdl
intraven
administr
plasma
combin
plasma
synthet
colloid
consid
soon
evid
consist
declin
total
plasma
protein
concentr
concentr
albumin
less
gdl
hors
develop
depend
edema
hors
requir
l
plasma
synthet
colloid
improv
plasma
oncot
pressur
fresh
fresh
frozen
plasma
ideal
addit
albumin
major
colloid
compon
blood
plasma
contain
compon
provid
system
support
includ
fibronectin
complement
inhibitor
elastas
proteinas
inhibitor
antithrombin
iii
hetastarch
may
administ
dosag
mlkg
larg
size
starch
molecul
solut
effect
plasma
volum
expand
result
sustain
dosedepend
decreas
pcv
plasma
protein
concentr
accompani
increas
oncot
pressur
administr
combin
hetastarch
plasma
effect
resuscit
emerg
situat
clinic
sign
suggest
sever
hypovolem
shock
l
total
colloid
solut
per
standard
size
adult
hors
hors
acut
coliti
absorb
larg
quantiti
endotoxin
across
disrupt
intestin
mucos
barrier
put
high
risk
develop
lamin
thrombophleb
nsaid
possibl
bowel
damag
induc
block
protect
effect
intestin
mucos
prostaglandin
endogen
prostaglandin
import
inhibitor
intestin
inflamm
block
agent
nonselect
nsaid
may
slow
recoveri
heal
inflam
intestin
mucosa
altern
potenti
analges
combin
minim
effect
gastrointestin
motil
butorphanol
mgkg
im
detomidin
mgkg
im
administ
everi
hour
altern
constant
butorphanol
infus
per
hour
iv
conveni
administ
ad
mg
butorphanol
l
lactat
ringer
solut
crystalloid
infus
rate
l
per
hour
hors
hors
geograph
risk
clinic
clinicopatholog
data
organ
identif
creat
high
suspicion
n
risticiiassoci
coliti
treatment
oxytetracyclin
mgkg
iv
everi
hour
effect
intraven
broadspectrum
antimicrobi
use
judici
hors
acut
coliti
unknown
etiolog
alway
indic
mild
transient
neutropenia
fever
may
justifi
use
broadspectrum
antimicrobi
agent
consid
hors
profound
persist
neutropenia
risk
complic
associ
sepsi
periton
pneumonia
cellul
thrombophleb
dissemin
intravascular
coagul
potassium
penicillin
g
iukg
slow
iv
everi
hour
combin
gentamicin
mgkg
iv
im
everi
hour
commonli
use
treatment
regimen
hors
ongo
system
diseas
oral
broadspectrum
antimicrobi
medic
recommend
potenti
disrupt
intestin
microbi
popul
oral
administ
metronidazol
mgkg
everi
hour
may
indic
hors
clostridium
spp
suspect
play
pathogen
role
diseas
latter
drug
may
local
antiinflammatori
effect
caus
loss
appetit
hors
effect
antisecretori
medic
target
larg
colon
hors
identifi
unlik
bismuth
subsalicyl
similar
protect
agent
effect
treat
larg
bowel
diarrhea
adult
hors
larg
volum
larg
intestin
content
ditrioctahedr
smectit
adsorb
substanc
endotoxin
exotoxin
bind
equineorigin
c
difficil
toxin
b
c
perfringen
enterotoxin
natur
hydrat
aluminomagnesium
silic
use
rational
activ
charcoal
univers
enter
adsorb
smectit
administ
earli
dose
kg
powder
mix
water
administ
nasogastr
tube
load
dose
follow
dose
kg
given
everi
hour
hors
acut
coliti
partial
complet
inappet
lose
protein
consequ
cachexia
proteinlos
enteropathi
partial
total
parenter
nutrit
may
indic
hors
remain
inappet
day
hors
coliti
often
appetit
encourag
continu
eat
goodqual
hay
fresh
green
grass
highli
digest
dissemin
intravascular
coagul
digit
puls
monitor
three
four
time
daili
system
sign
coliti
abat
along
intraven
fluid
gener
support
care
measur
treatment
specif
aim
combat
endotoxemia
crucial
patient
surviv
primari
target
area
manag
treat
endotoxemia
hors
acut
coliti
includ
neutral
endotoxin
interact
inflammatori
cell
prevent
synthesi
releas
action
mediat
activ
gener
support
care
measur
endoserum
hyperimmun
serum
obtain
hors
vaccin
salmonella
typhimurium
mutant
mlkg
iv
dilut
steril
isoton
salin
lactat
ringer
solut
dilut
ratio
recommend
minim
risk
immunemedi
hypersensit
reaction
polymyxin
b
iukg
iv
everi
hour
day
bind
neutral
endotoxin
lipid
region
endotoxin
molecul
potenti
nephrotox
effect
polymyxin
b
use
judici
use
azotem
hors
recommend
lowdos
administr
flunixin
meglumin
mg
kg
iv
everi
hour
recommend
prevent
endotoxininduc
prostanoid
synthesi
hors
compar
regimen
involv
nsaid
flunixin
meglumin
lower
risk
advers
effect
includ
gastrointestin
ulcer
ileu
renal
papillari
necrosi
inhibitor
drug
firocoxib
fewer
advers
effect
use
altern
nonselect
nsaid
administr
corticosteroid
inhibit
arachidon
acid
pathway
mediat
activ
vitro
clinic
use
drug
may
associ
increas
risk
lamin
singl
dose
shortact
corticosteroid
eg
prednisolon
sodium
succin
mgkg
iv
may
help
acut
stage
endotoxemia
without
increas
risk
lamin
administr
dimethylsulfoxid
gkg
iv
solut
less
may
use
block
lipid
peroxid
higher
dose
associ
exacerb
intestin
reperfus
injuri
hors
allopurinol
mgkg
iv
also
administ
block
lipid
peroxid
pentoxifyllin
mgkg
po
iv
steril
powder
given
dilut
fluid
everi
hour
phosphodiesteras
inhibitor
may
use
hors
risk
develop
lamin
block
endotoxininduc
cytokin
thromboxan
thromboplastin
product
nonsteroid
antiinflammatori
drug
frequent
use
group
drug
treat
abdomin
pain
hors
typic
drug
use
includ
flunixin
meglumin
mgkg
iv
everi
hour
phenylbutazon
mgkg
iv
everi
hour
phenylbutazon
may
contribut
damag
intestin
epitheli
barrier
lower
less
frequent
dose
consid
select
inhibitor
firocoxib
safer
hors
similar
benefici
antiinflammatori
effect
use
consid
lieu
nonselect
nsaid
veterinarian
must
weigh
benefici
analges
effect
nonselect
endoserum
immvac
inc
columbia
mo
protein
concentr
feed
hors
continu
eat
usual
better
chanc
recoveri
probiot
administr
may
use
restor
colon
resist
colon
disrupt
antimicrobialinduc
c
difficileassoci
coliti
advers
effect
may
aris
unapprov
product
use
veterinarian
must
educ
client
method
safe
practic
use
safe
approv
equin
biotherapeut
product
transfaun
fecal
liquor
healthi
hors
use
extrem
import
confirm
diseasefre
statu
donor
hors
salmonellosi
transmit
rout
result
procedur
equivoc
regard
benefit
patient
rapid
institut
appropri
treatment
measur
improv
prognosi
hors
acut
coliti
howev
affect
hors
deterior
rapidli
even
face
aggress
medic
treatment
hors
continu
frequent
profus
wateri
diarrhea
ongo
system
sign
endotoxemia
septicemia
poorer
prognosi
recoveri
diarrheic
hors
azotem
clinicopatholog
find
consist
ongo
hemoconcentr
hypoproteinemia
also
poor
prognosi
surviv
antimicrobi
administr
may
induc
diarrhea
hors
antimicrobialassoci
diarrhea
may
wors
prognosi
type
acut
diarrhea
frequent
complic
acut
equin
coliti
includ
lamin
thrombophleb
debilit
mark
weight
loss
